In this review from Neurodegenerative Disease Management, explore current research into visual dysfunction in Alzheimer’s disease pathology.
Browsing: optic neuropathy
Jutley et al. discuss established glaucoma treatments, review promising new neuroprotective agents, and explore potential future treatments targeting the neurodenegerative processes in glaucoma.
A common antihistamine has demonstrated potential efficacy in reversing myelin damage in Multiple Sclerosis patients with optic neuropathy.